John W. Rogers Jr.'s position in Haemonetics is currently worth $224M. That's 2.41% of their equity portfolio (10th largest holding). The investor owns 4.54% of the outstanding Haemonetics stock. The stake costed the investor $133M, netting the investor a gain of 69% so far.